Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

A High-Throughput Screen Identifies DYRK1A Inhibitor ID-8 that Stimulates Human Kidney Tubular Epithelial Cell Proliferation

Full text
Author(s):
Monteiro, Maria B. [1] ; Ramm, Susanne [1, 2] ; Chandrasekaran, Vidya [1] ; Boswell, Sarah A. [1] ; Weber, Elijah J. [3] ; Lidberg, Kevin A. [3] ; Kelly, Edward J. [3] ; Vaidya, Vishal S. [4, 1, 2]
Total Authors: 8
Affiliation:
[1] Harvard Med Sch, Lab Syst Pharmacol, Harvard Program Therapeut Sci, Boston, MA - USA
[2] Brigham & Womens Hosp, Dept Med, Renal Div, 75 Francis St, Boston, MA 02115 - USA
[3] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 - USA
[4] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA - USA
Total Affiliations: 4
Document type: Journal article
Source: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY; v. 29, n. 12, p. 2820-2833, DEC 2018.
Web of Science Citations: 2
Abstract

Background The death of epithelial cells in the proximal tubules is thought to be the primary cause of AKI, but epithelial cells that survive kidney injury have a remarkable ability to proliferate. Because proximal tubular epithelial cells play a predominant role in kidney regeneration after damage, a potential approach to treat AKI is to discover regenerative therapeutics capable of stimulating proliferation of these cells. Methods We conducted a high-throughput phenotypic screen using 1902 biologically active compounds to identify new molecules that promote proliferation of primary human proximal tubular epithelial cells in vitro. Results The primary screen identified 129 compounds that stimulated tubular epithelial cell proliferation. A secondary screen against these compounds over a range of four doses confirmed that eight resulted in a significant increase in cell number and incorporation of the modified thymidine analog EdU (indicating actively proliferating cells), compared with control conditions. These eight compounds also stimulated tubular cell proliferation in vitro after damage induced by hypoxia, cadmium chloride, cyclosporin A, or polymyxin B. ID-8, an inhibitor of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A), was the top candidate identified as having a robust proproliferative effect in two-dimensional culture models as well as a microphysiologic, three-dimensional cell culture system. Target engagement and genetic knockdown studies and RNA sequencing confirmed binding of ID-8 to DYRK1A and upregulation of cyclins and other cell cycle regulators, leading to epithelial cell proliferation. Conclusions We have identified a potential first-in-class compound that stimulates human kidney tubular epithelial cell proliferation after acute damage in vitro. (AU)

FAPESP's process: 16/04935-2 - Validation of candidate mRNAs and miRNAs as biomarkers of diabetic nephropathy in a North-American cohort of type 1 and type 2 diabetes patients
Grantee:Maria Beatriz Camargo Monteiro Caillaud
Support type: Scholarships abroad - Research Internship - Post-doctor